Introduction
Medulloblastoma is the most common malignant, invasive, childhood embryonal tumor that occurs typically in midline posterior fossa. Approximately 500 children are diagnosed with medulloblastoma each year in the United States. It accounts for 20% of all pediatric tumors, with a peak age distribution of 5-9 years old and a preponderance for males [1] . Medulloblastoma typically presents midline or paramedian in the cerebellum, often compressing and invading the fourth ventricle. Diagnosis requires histopathologic confirmation at time of resection [2] . Children diagnosed at younger than 5 years of age, and especially those younger than 3, have been shown to have poorer prognosis with an estimated 5-year survival of 32% [3] . That said, histopathologic and molecular subtype have 
Available online at www.sciencedirect.com ScienceDirect j o u r n a l h o m e p a g e : h t t p : / / E l s e v i e r. c o m / l o c a t e / r a d c r been used to stratify patients into risk categories and determine appropriate therapy [4] . Herein, we present the atypical case of a 33-month-old patient diagnosed with medulloblastoma presenting in a rare location overlying the cerebellar hemisphere posterolateral to the cerebellopontine angle.
Case report
A 33-month-old white male presented with 1-week history of increased sleepiness, abdominal pain, emesis, and diarrhea previously diagnosed as constipation and dehydration. Initial contrast-enhanced (CE) head computed tomography (CT) scan demonstrated an enhancing mass overlying the right cerebellar hemisphere with secondary mass effect on adjacent structures including effacement of the fourth ventricle, resulting in hydrocephalus (Fig. 1) . Subsequent contrast-enhanced magnetic resonance imaging (CEMRI) brain depicted a wellcircumscribed, extra-axial T2 hyperintense mass in the right posterior fossa measuring 4.3 × 4.7 × 3.1 cm, which exerted mass effect on the right cerebellar hemisphere, causing slight inferior herniation of the right cerebellar tonsil as well as effacement of the fourth ventricle and resulting in obstructive hydrocephalus. The mass demonstrated restricted diffusion on diffusion-weighted images (Figs. 2-8 ). Given the infratentorial location in the posterior fossa, mild heterogeneous enhancement, and age of the patient, extra-axial medulloblastoma was considered with hemangioblastoma, astrocytoma, meningioma, or an atypical teratoid-rhabdoid tumor in the differential. Concurrently performed whole-spine CEMRI was unremarkable, except for a small linear enhancement along the posterior margin of the thoracic spinal cord at T9-T10, which was not definitive of metastasis.
An emergent craniectomy with resection of the mass was performed. Macroscopically, a significantly bloody, slightly discolored mass was observed extra-axially in the right cerebellar hemisphere. A gross total surgical excision of the tumor was performed. Microscopically, frozen section showed a small, round, blue cell tumor. Hemotoxylin and eosin stain revealed marked hypercellular tissue with areas of primitive histology and areas of mild differentiation with a small foci of cells in a desmoplastic pattern with anaplasia (Figs. 9-10 ). Ki-67 was over 5% positive nuclei and GFAP was found to be focally positive. These findings were consistent with medulloblastoma (World Health Organization grade IV).
Postoperative CEMRI brain revealed no evidence of remnant enhancing lesion in the right cerebellar hemisphere and showed improvement of hydrocephalus and mass effect on the fourth ventricle when compared to the previous study. The postoperative course was uneventful, with rapid resolution of symptoms. Although medulloblastomas are radiosensitive, for children less than 3 years, radiotherapy is avoided. Adjuvant chemotherapy beginning 21 days postoperative to the resection is instead suggested. The patient was enrolled in the "Head Start 4" study [5] . 
Discussion
Medulloblastomas are the most common malignant brain tumor of childhood, accounting for 16%-20% of all childhood tumors [6, 7] . They are invasive embryonal tumors occurring almost exclusively in the posterior fossa involving cerebellum. Medulloblastomas were previously thought to represent a subset of primitive neuroectodermal tumors (PNETs) of the posterior fossa [8] , but have recently been shown to be distinct via DNA microarray gene expression data [9] . The cell of origin is controversial, but is thought to originate from germinal cells or their remnant situated at the end of the posterior medullary velum or from the proliferating remnants of the external granular layer of the cerebellar hemispheres, including the flocculus [10] [11] [12] .
The tumor typically presents as a contrast-enhancing mass midline in the cerebellar vermis, often compressing the fourth ventricle [13] . Zee et al. reported a study of 129 histologically verified tumors of the posterior fossa and determined that medulloblastoma frequently exhibits increased density compared with adjacent cerebellum and can be diagnosed with high likelihood when there is a central mass exhibiting well-demarcated borders [14] . Only 35 cases of medulloblastoma have been reported to be extra-axial in nature, most of which occur in the cerebellopontine angle [15] [16] [17] . The extra-axial finding alongside a purely hemispheric presentation of the tumor makes our patient's case quite rare in the pediatric population. It has been suggested that 50% of adult medulloblastomas arise from the surface of the cerebellum or pons in a lateral location. Histopathologically, medulloblastoma is a heterogenous, small, blue cell tumor. They are highly cellular, with abundant mitoses and little cytoplasmic differentiation. Neuroblastic Homer Wright rosettes are present in up to 40% of cases [18] .
No clinical manifestations of medulloblastoma have been related specifically to location of the tumor. However, some characteristics of posterior fossa tumors such as progressive cerebellar signs and gait ataxia may be seen, although usually favoring an intra-axial location. Headache, nausea, and vomiting are less distinguishable symptoms commonly reported in medulloblastoma cases [17] . Additional differential diagnoses, such as posterior fossa epidermoid cyst, hemangioblastoma, pilocytic astrocytoma, and atypical tertoid-rhabdoid tumor, may also be included. Epidermoid cysts are uncommon benign tumors that can present in the posterior fossa in both adult and pediatric patients. They are often referred to as "pearly tumors," considering their high lipid and cholesterol components that make them characteristically well-demarcated and hypodense on CT. They are further differentiated by cerebrospinal fluid intensity on MRI, including minimal peripheral enhancement and characteristic restricted diffusion on diffusion-weighted images [19] . Juvenile pilocytic astrocytomas (JPAs) often demonstrate pathognomonic mural nodule T1WI (B) . T1WI, T1-weighted imaging.
[20] enhancement within an infratentorial cystic lesion, and they can also be seen within the hypothalamus or along the optic pathways. In contrast to medulloblastoma, these tumors are hypoattenuated on unenhanced CT in view of ample cytoplasm and relatively less compact matrix [21] . These tumors are rarely seen in adulthood. In contrast, hemangioblastomas present in young and middle-aged adults and have nearly identical imaging characteristics to that of JPAs. Other distinctions from JPAs include their relatively high intrinsic vascularity as evidenced by high rCBV values on perfusion MRI, and if seen in multiples, their high association with Von Hippel-Lindau (VHL) syndrome [20] [21] [22] . Atypial teratoid-rhabdoid tumors constitute approximately 1%-2% of all pediatric central nervous system tumors and present as a heterogenous solid-cystic mass, occurring off-midline in children <3 years of age. They are commonly misdiagnosed as medulloblastoma owing to difficulty in distinction on radiology alone [23] .
Treatment and prognosis of extra-axial medulloblastoma is undefined because of the small number of cases reported. Histologic variants, "classic" vs "desmoplastic," were initially thought to provide some insight, but have subsequently been refuted [24] . Genetically defined molecular subgroups, via the World Health Organization, may play a better role in prognosis. Four distinct subgroups have been defined: sonic hedgehog (SHH), Wingless (WNT), group 3, and group 4. WNT has been shown to have the best prognosis, whereas group 3 tends to have the worst [25] . However, treatment is welldefined in all cases of medulloblastoma and consists of combined surgery with radiation therapy or chemotherapy in most patients [26] . Metastasis presents at diagnosis in onethird of children [27] . In contrast to nonmetastatic medulloblastoma, gold-standard treatment for metastatic medulloblastoma has not been well defined. A recent study by von Bueren et al. suggests that combined intensive non-high dose chemotherapy or autologous stem-cell transplantation with hyperfractionated, nonaccelerated radiotherapy is encouraging for improved 5-year survival and overall survival trends [28] .
Conclusion
Medulloblastoma is an exceedingly common childhood tumor that nearly always presents intra-axially involving the fourth ventricle. Nonetheless, our case illustrates that an extraaxial enhancing mass found in the posterior fossa of a pediatric patient requires consideration of infrequent extra-axial medulloblastoma in differential diagnosis.
